Nitrogen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. The precise indications and usage have not been explicitly stated in the provided information.

Healthcare professionals are advised to consider the absence of information regarding teratogenic and nonteratogenic effects when prescribing this medication. Further evaluation of the drug's safety profile and clinical efficacy is recommended to ensure appropriate use in targeted patient populations.

Dosage and Administration

Administration of Nitrogen is indicated via respiratory inhalation. The active ingredient consists of Nitrogen 99 L in 100 L. Due to the potential hazards associated with the use of Nitrogen, it is imperative that administration is conducted only by or under the supervision of a licensed practitioner experienced in its use.

Nitrogen must be utilized and stored exclusively outdoors or in a well-ventilated area to ensure safety. After each use, the valve should be closed, and the container must be kept in an upright position at all times. It is essential to ensure that the container is not empty before closing the valve to maintain proper handling and safety protocols.

Contraindications

There are no specific contraindications identified for this product. However, the following precautions must be observed to ensure safe use:

• Do not remove fittings or change connections, as this may compromise safety and functionality.

• Do not handle the product until all safety precautions have been thoroughly read and understood.

• Use and store the product exclusively outdoors or in a well-ventilated area to minimize exposure to potentially harmful substances.

• Do not remove the product label, as it contains essential safety and usage information.

Warnings and Precautions

Administration of Nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that this substance be used solely by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrogen. Such practitioners must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration. Additionally, they should be knowledgeable about the associated hazards, contraindications, side effects, and necessary precautions to ensure safe usage.

Healthcare professionals should be aware that Nitrogen is a refrigerated gas, which can lead to cryogenic burns or injuries if not handled properly. Furthermore, the gas has the potential to displace oxygen in the environment, creating a risk of rapid suffocation. It is crucial to implement appropriate safety measures to mitigate these risks during administration.

Side Effects

Administration of Nitrogen may pose significant risks and is contraindicated in certain situations. It is essential that this substance be used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Such practitioners should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be aware that Nitrogen is a refrigerated gas, which may lead to cryogenic burns or injuries if not handled properly. Additionally, the gas has the potential to displace oxygen in the environment, which can result in rapid suffocation. These warnings highlight the importance of adhering to safety protocols during the administration of Nitrogen to mitigate the risk of serious adverse reactions.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication. The prescribing information does not include recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety and efficacy of this drug during pregnancy have not been established, as it has not been approved by the FDA. The administration of Nitrogen may pose potential risks to pregnant patients and is considered hazardous or contraindicated. Therefore, it is recommended that this drug be used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. Healthcare professionals should ensure that they are familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions when considering the use of this drug in pregnant patients.

Lactation

There is no specific information regarding the use of Nitrogen, Refrigerated Liquid in lactating mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this product to nursing mothers. The absence of data on excretion in breast milk and effects on breastfed infants necessitates careful clinical judgment in these cases.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, including monitoring vital signs and providing symptomatic treatment as necessary. In cases of significant overdose, consultation with a poison control center or a medical toxicologist is recommended to determine the most appropriate course of action.

It is crucial for healthcare professionals to educate patients and caregivers about the importance of adhering to prescribed dosages and to provide guidance on what to do in the event of a suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has revealed that the drug has not been found by the FDA to be safe and effective, and its labeling has not received FDA approval. Reports indicate that the administration of Nitrogen may pose hazards or be contraindicated, necessitating use only by or under the supervision of a licensed practitioner experienced in its use. This practitioner should be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Additionally, it is important to note that the product contains refrigerated gas, which may lead to cryogenic burns or injury. There is also a risk of oxygen displacement, potentially resulting in rapid suffocation.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning regarding the product's nature, noting that it contains refrigerated gas, which may lead to cryogenic burns or injuries. Additionally, patients should be made aware that Nitrogen can displace oxygen, potentially resulting in rapid suffocation.

Patients should be instructed not to handle Nitrogen until they have read and understood all safety precautions. It is crucial to use and store Nitrogen only outdoors or in a well-ventilated area. They should be advised to wear cold insulating gloves, a face shield, and eye protection during handling. Providers should also inform patients about the importance of using a backflow preventive device in the piping and to avoid changing or forcing connections. Patients should be reminded to close the valve after each use and when the container is empty, and to always keep the container in an upright position. They should read and follow the Safety Data Sheet (SDS) prior to use.

In the event of inhalation, patients should be instructed to remove themselves to fresh air and maintain comfort while breathing. If Nitrogen comes into contact with the skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in a container that must be kept in an upright position at all times. It is essential to use and store the product exclusively outdoors or in a well-ventilated area to ensure safety.

When handling the product, personnel are required to wear cold insulating gloves, a face shield, and eye protection to minimize exposure risks. It is crucial to close the valve after each use and when the container is empty to prevent any accidental release.

Prior to handling, all safety precautions must be thoroughly read and understood. A backflow preventive device should be utilized in the piping to maintain system integrity. Connections should not be changed or forced to fit, as this may compromise safety.

For comprehensive safety information, it is imperative to read and follow the Safety Data Sheet (SDS) before use.

Additional Clinical Information

Patients should be informed that the route of administration for the product is via respiratory inhalation. Clinicians should emphasize the importance of adhering to safety precautions prior to handling the product. This includes using and storing the product only outdoors or in well-ventilated areas, wearing appropriate protective gear such as cold insulating gloves, face shields, and eye protection, and utilizing a backflow preventive device in the piping.

Additionally, it is crucial to avoid changing or forcing connections, to close the valve after each use and when the container is empty, and to always keep the container in an upright position. Patients should also be advised to read and follow the Safety Data Sheet (SDS) before use to ensure safe handling and application.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Messer Gas Puerto Rico, Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)